CALIFORNIA NANOTECHNOLOGIES(TSX-V:CNO) stock Fundamental Analysis

Fundamental Rating

Overall CNO gets a fundamental rating of 4 out of 10. We evaluated CNO against 82 industry peers in the Insurance industry. CNO has only an average score on both its financial health and profitability. CNO has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CNO has reported negative net income.

In the past year CNO had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: CNO reported negative net income in multiple years.

In the past 5 years CNO always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of CNO (-3.94%) is worse than 96.34% of its industry peers.

CNO has a Return On Equity of -12.90%. This is amonst the worse of the industry: CNO underperforms 96.34% of its industry peers.

Looking at the Return On Invested Capital, with a value of 37.09%, CNO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

Measured over the past 3 years, the Average Return On Invested Capital for CNO is significantly above the industry average of 2.83%.

The 3 year average ROIC (32.10%) for CNO is below the current ROIC(37.09%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	-3.94%
ROE	-12.9%
ROIC	37.09%

ROA(3y)14.93%

ROA(5y)2%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)32.1%

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 29.53%, CNO belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.

In the last couple of years the Operating Margin of CNO has grown nicely.

CNO's Gross Margin of 74.73% is amongst the best of the industry. CNO outperforms 98.78% of its industry peers.

CNO's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	29.53%
PM (TTM)	N/A
GM	74.73%

OM growth 3YN/A

OM growth 5Y63.01%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y6.54%

GM growth 5Y1.16%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CNO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.

CNO has more shares outstanding than it did 1 year ago.

CNO has more shares outstanding than it did 5 years ago.

CNO has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 3.65 indicates that CNO is not in any danger for bankruptcy at the moment.

CNO's Altman-Z score of 3.65 is amongst the best of the industry. CNO outperforms 100.00% of its industry peers.

The Debt to FCF ratio of CNO is 5.03, which is a neutral value as it means it would take CNO, 5.03 years of fcf income to pay off all of its debts.

With a Debt to FCF ratio value of 5.03, CNO is not doing good in the industry: 96.34% of the companies in the same industry are doing better.

CNO has a Debt/Equity ratio of 0.97. This is a neutral value indicating CNO is somewhat dependend on debt financing.

The Debt to Equity ratio of CNO (0.97) is worse than 95.12% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.97
Debt/FCF	5.03
Altman-Z	3.65

ROIC/WACC4.24

WACC8.75%

2.3 Liquidity

CNO has a Current Ratio of 0.79. This is a bad value and indicates that CNO is not financially healthy enough and could expect problems in meeting its short term obligations.

CNO has a better Current ratio (0.79) than 90.24% of its industry peers.

A Quick Ratio of 0.79 indicates that CNO may have some problems paying its short term obligations.

The Quick ratio of CNO (0.79) is better than 90.24% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.79
Quick Ratio	0.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CNO have decreased strongly by -132.26% in the last year.

Looking at the last year, CNO shows a very strong growth in Revenue. The Revenue has grown by 123.06%.

CNO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.80% yearly.

EPS 1Y (TTM)-132.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-84.93%

Revenue 1Y (TTM)123.06%

Revenue growth 3Y61.35%

Revenue growth 5Y34.8%

Sales Q2Q%55.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNO. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNO is valued a bit cheaper than 64.63% of the companies in the same industry.

CNO's Price/Free Cash Flow ratio is rather expensive when compared to the industry. CNO is more expensive than 97.56% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	43.6
EV/EBITDA	8.51

4.3 Compensation for Growth

The decent profitability rating of CNO may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CNO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CALIFORNIA NANOTECHNOLOGIES

TSX-V:CNO (5/6/2025, 7:00:00 PM)

0.51

-0.01 (-1.92%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupInsurance

GICS IndustryInsurance

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners13.76%

Ins Owner ChangeN/A

Market Cap23.82M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.85
P/FCF	43.6
P/OCF	7.04
P/B	9.8
P/tB	9.82
EV/EBITDA	8.51

EPS(TTM)-0.01

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.01

FCFY2.29%

OCF(TTM)0.07

OCFY14.21%

SpS0.18

BVpS0.05

TBVpS0.05

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.94%
ROE	-12.9%
ROCE	51.51%
ROIC	37.09%
ROICexc	41.97%
ROICexgc	42.01%
OM	29.53%
PM (TTM)	N/A
GM	74.73%
FCFM	6.53%

ROA(3y)14.93%

ROA(5y)2%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)32.1%

ROIC(5y)N/A

ROICexc(3y)62.05%

ROICexc(5y)N/A

ROICexgc(3y)62.77%

ROICexgc(5y)N/A

ROCE(3y)-1.36%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5Y78.27%

ROICexc growth 3YN/A

ROICexc growth 5Y84.63%

OM growth 3YN/A

OM growth 5Y63.01%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y6.54%

GM growth 5Y1.16%

F-Score5

Asset Turnover1.05

Health

		Industry Rank	Sector Rank
Debt/Equity	0.97
Debt/FCF	5.03
Debt/EBITDA	0.77
Cap/Depr	484.23%
Cap/Sales	33.95%
Interest Coverage	250
Cash Conversion	110.78%
Profit Quality	N/A
Current Ratio	0.79
Quick Ratio	0.79
Altman-Z	3.65

F-Score5

WACC8.75%

ROIC/WACC4.24

Cap/Depr(3y)25.35%

Cap/Depr(5y)N/A

Cap/Sales(3y)2.45%

Cap/Sales(5y)N/A

Profit Quality(3y)254.9%

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-132.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-84.93%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)123.06%

Revenue growth 3Y61.35%

Revenue growth 5Y34.8%

Sales Q2Q%55.81%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y178.73%

EBIT growth 3YN/A

EBIT growth 5Y119.74%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-26.23%

FCF growth 3Y53.47%

FCF growth 5Y4.28%

OCF growth 1Y338.58%

OCF growth 3Y61.2%

OCF growth 5Y2.23%

CALIFORNIA NANOTECHNOLOGIES (CNO.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens